Effects of Grape Consumption on the Immune-Gut Axis in Obesity (NCT07231484) | Clinical Trial Compass
RecruitingNot Applicable
Effects of Grape Consumption on the Immune-Gut Axis in Obesity
United States50 participantsStarted 2025-12-19
Plain-language summary
This study is investigating the benefits of whole freeze-dried grape powder consumption on the immune-gut axis in adults with obesity.
Who can participate
Age range30 Years – 45 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age: 30-45 years
* Obesity with BMI of 30-45 kg/m2
* Willingness to consume study foods
* Consistent diet and activity patterns for 4 weeks
* Weight stable (\<5kg change over last 3 months)
* Non-smoker \> 1 year or more
* Not currently consuming an extremely healthy diet
Exclusion Criteria:
* Study food allergies
* Regular consumption of grapes or grape-derived products
* Gastrointestinal disease and/or bariatric surgery
* Uncontrolled hypertension and blood pressure \>180/110
* Diabetes
* Clinical Depression
* Illicit drug use
* History of alcohol or drug abuse
* Recent use of medications that affect immune function (e.g., corticosteroids)
* Recent consumption of antibiotics, prebiotics, probiotics, symbiotics, or dietary supplements containing fiber or phytochemicals
* Pregnant or lactating individuals
* HIV positivity
* Recent start of medications that affect metabolism or appetite
* Drug therapy for coronary artery disease, peripheral artery disease, congestive heart failure, or dyslipidemia
What they're measuring
1
Gut microbial diversity
Timeframe: Baseline, Week 4, Week 8, Week 12
2
LPS-binding protein concentration
Timeframe: Baseline, Week 4, Week 8, Week 12
3
Cytokine concentrations following PBMC stimulation